Filter
154
Text search:
Corticosteroids
Featured
Recommendations
37
New Publications
33
Language
Document type
No document type
66
Guidelines
53
Studies & Reports
20
Strategic & Response Plan
5
Fact sheets
4
Training Material
3
Manuals
2
Resource Platforms
1
Countries / Regions
India
21
Global
11
Kenya
7
Africa
7
South Africa
6
Ethiopia
3
Tanzania
3
Malawi
3
West and Central Africa
3
Western and Central Europe
3
Russia
3
Senegal
2
USA
2
Philippines
2
Germany
2
Cambodia
2
Bangladesh
2
Latin America and the Carribbean
2
Spain
2
Sierra Leone
1
Nigeria
1
Congo, Democratic Republic of
1
Ghana
1
Uganda
1
Haiti
1
Iraq
1
Zambia
1
Syria
1
Rwanda
1
Namibia
1
Eswatini/ Swaziland
1
Brazil
1
Ukraine
1
Myanmar / Burma
1
East and Southern Africa
1
Middle East and North Africa
1
Paraguay
1
Iran
1
Authors & Publishers
Publication Years
Category
Countries
67
Clinical Guidelines
32
Public Health
12
Women & Child Health
7
Key Resources
2
Toolboxes
COVID-19
23
NCDs
19
TB
16
NTDs
10
HIV
5
AMR
5
Pharmacy
5
Mental Health
3
Ebola & Marburg
2
Rapid Response
2
Refugee
2
Zika
2
Specific Hazards
2
Caregiver
2
Conflict
1
Health Financing Toolbox
1
Malaria
1
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients
...
The document discusses the complexities of managing patients with COPD and multiple comorbidities, highlighting the importance of personalized care and the appropriate use of inhaled corticosteroids (ICS). It outlines common comorbidities, such as a
...
The article "Asthma treatment in children: A guide to screening for and management of hypothalamic-pituitary-adrenal axis suppression" discusses the risks associated with the use of corticosteroids in pediatric asthma treatment. It highlights that p
...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati
...
Over 90% of the morbidity and mortality related to chronic obstructive pulmonary disease (COPD) and asthma occurs in low-income and middle-income countries (LMICs) due to well documented factors including decreased access to screening, trained health professionals, and therapies for disease manageme
...
sthma prevalence is increasing worldwide, and surveys indicate that most patients in developed and developing countries, including South Africa, do not receive optimal care and are therefore not well controlled. Standard management guidelines adapted to in-country realities are important to support
...
The article "Barriers and determinants of asthma control in children and adolescents in Africa: a systematic review" analyzes factors contributing to poor asthma control in African youth. Based on studies conducted between 2014 and 2019 in Nigeria, Uganda, and South Africa, the review identifies key
...
This document contains: The systematic reviews and GRADE assessments used at the Index-TB Guideline Panel in July 2015; The Evidence to Decision tables that record the Panel’s assessment and recommendations from
this meeting
Every Newborn: an action plan to end preventable deaths is a roadmap for change. It takes forward the Global Strategy for Women’s and Children’s Health by focusing specific attention on newborn health and identifying actions for improving their survival, health and development.
Flow Charts
This guidance covers diagnosis and care of patients with long-term effects of COVID-19. It makes recommendations for the care of adults and children who have new or ongoing symptoms 4 weeks or more after the start of acute COVID-19. It is meant for health and care practitioners. This interim documen
...
The information provided here can be used to understand the current situation, increase attention to preterm births in Rwanda and to inform dialogue and action among stakeholders. Data can be used to identify the most important risk factors to target and gaps in care in order to identify and impleme
...
Asthma is a serious global health problem affecting all age groups. Its prevalence is increasing in many countries, espacially among children. Although some countries have seen a decline in hospitalizations and deaths from asthma, asthma still imposes an unacceptable burden on health care systems, a
...
Asthma is the commonest chronic childhood disease and encompasses a spectrum of airway diseases with similar symptoms. Inaccurate diagnosis remains common, especially in younger children, with failure to characterize the different “asthmas.” Children worldwide repeatedly suffer symptoms which se
...
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for
...
Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi
...
The European Respiratory Society (ERS)/American Thoracic Society (ATS) Task Force on severe asthma includes an updated definition of severe asthma, a discussion of severe asthma phenotypes in relation to genetics, natural history, pathobiology and physiology, as well as sections on evaluation and tr
...
Asthma is the most common chronic condition in children worldwide. It affects daytime activities, sleep and school attendance and causes anxiety to parents, families and other carers. The quality of asthma diagnosis and management globally still needs substantial improvement. From infancy to the tee
...
